408 related articles for article (PubMed ID: 28128811)
1. [Herpes zoster and post-herpetic neuralgia in the elderly: Particularities in prevention, diagnosis, and treatment].
García-González AI; Rosas-Carrasco O
Gac Med Mex; 2017; 153(1):92-101. PubMed ID: 28128811
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review.
Koshy E; Mengting L; Kumar H; Jianbo W
Indian J Dermatol Venereol Leprol; 2018; 84(3):251-262. PubMed ID: 29516900
[TBL] [Abstract][Full Text] [Related]
3. [Herpes zoster in old adults].
Lang PO; Belmin J; Michel JP
Presse Med; 2009 Apr; 38(4):571-83. PubMed ID: 19028069
[TBL] [Abstract][Full Text] [Related]
4. [Herpes zoster and post-herpetic neuralgia in older adults].
Lang PO; Zarate-Lagunes M; Pautex S
Rev Med Suisse; 2008 Nov; 4(178):2398-402, 2404. PubMed ID: 19051627
[TBL] [Abstract][Full Text] [Related]
5. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster.
O'Connor KM; Paauw DS
Med Clin North Am; 2013 Jul; 97(4):503-22, ix. PubMed ID: 23809711
[TBL] [Abstract][Full Text] [Related]
7. [Zoster and postherpetic neuralgia: vaccine prevention is available].
Belmin J; Jarzebowski W; Lafuente-Lafuente C
Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13 Suppl 2():15-20. PubMed ID: 26967927
[TBL] [Abstract][Full Text] [Related]
8. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
Marino MG; Bagnato B; Torella I; Franco E
Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
[TBL] [Abstract][Full Text] [Related]
9. The burden of herpes zoster and postherpetic neuralgia in the United States.
Weaver BA
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination against herpes-zoster: a new strategy for post-herpetic neuralgia].
Gil de Miguel A
An R Acad Nac Med (Madr); 2009; 126(1):57-66; discussion 67-72. PubMed ID: 20432659
[TBL] [Abstract][Full Text] [Related]
11. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
12. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
13. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
14. [Pain in herpes zoster: Prevention and treatment].
Calvo-Mosquera G; González-Cal A; Calvo-Rodríguez D; Primucci CY; Plamenov-Dipchikov P
Semergen; 2017; 43(4):318-327. PubMed ID: 27053513
[TBL] [Abstract][Full Text] [Related]
15. Prevention of herpes zoster and its painful and debilitating complications.
Johnson R; McElhaney J; Pedalino B; Levin M
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
[TBL] [Abstract][Full Text] [Related]
16. The impact of varicella zoster virus: chronic pain.
Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
Hoshi SL; Kondo M; Okubo I
Vaccine; 2017 May; 35(24):3264-3271. PubMed ID: 28479176
[TBL] [Abstract][Full Text] [Related]
18. Herpes zoster in outpatient departments of healthcare centers in India: a review of literature.
Patki A; Vora A; Parikh R; Kolhapure S; Agrawal A; Dash R
Hum Vaccin Immunother; 2021 Nov; 17(11):4155-4162. PubMed ID: 34520327
[TBL] [Abstract][Full Text] [Related]
19. Prevention and management of trigeminal herpes zoster and postherpetic neuralgia.
Closmann JJ; Fielding CG; Pogrel MA
Gen Dent; 2008; 56(6):563-6; quiz 567-8, 591-2. PubMed ID: 18810918
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
